These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Lipoprotein(a) and the cardiovascular risk]. Pedro-Botet J; Sentí M Rev Esp Cardiol; 1994 Sep; 47(9):583-6. PubMed ID: 7973023 [No Abstract] [Full Text] [Related]
26. Lipoprotein(a) levels are associated with aortic valve calcification in asymptomatic patients with familial hypercholesterolaemia. Vongpromek R; Bos S; Ten Kate GJ; Yahya R; Verhoeven AJ; de Feyter PJ; Kronenberg F; Roeters van Lennep JE; Sijbrands EJ; Mulder MT J Intern Med; 2015 Aug; 278(2):166-73. PubMed ID: 25487646 [TBL] [Abstract][Full Text] [Related]
27. Lipoprotein(a) and the Apolipoprotein B/A1 Ratio Independently Associate With Surgery for Aortic Stenosis Only in Patients With Concomitant Coronary Artery Disease. Ljungberg J; Holmgren A; Bergdahl IA; Hultdin J; Norberg M; Näslund U; Johansson B; Söderberg S J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29246959 [TBL] [Abstract][Full Text] [Related]
28. [Not Available]. von Eckardstein A Praxis (Bern 1994); 2017 Aug; 106(17):941-948. PubMed ID: 28830319 [No Abstract] [Full Text] [Related]
29. Causal association between adiposity and cardiovascular disease. Larsson SC Eur Heart J; 2019 Sep; 40(35):2937-2938. PubMed ID: 31520584 [No Abstract] [Full Text] [Related]
30. Relation of aortic valve calcium to chronic kidney disease (from the Chronic Renal Insufficiency Cohort Study). Guerraty MA; Chai B; Hsu JY; Ojo AO; Gao Y; Yang W; Keane MG; Budoff MJ; Mohler ER; Am J Cardiol; 2015 May; 115(9):1281-6. PubMed ID: 25791240 [TBL] [Abstract][Full Text] [Related]
31. A Replicated, Genome-Wide Significant Association of Aortic Stenosis With a Genetic Variant for Lipoprotein(a): Meta-Analysis of Published and Novel Data. Cairns BJ; Coffey S; Travis RC; Prendergast B; Green J; Engert JC; Lathrop M; Thanassoulis G; Clarke R Circulation; 2017 Mar; 135(12):1181-1183. PubMed ID: 28320808 [No Abstract] [Full Text] [Related]
32. The re-emergence of lipoprotein(a) in a broader clinical arena. Tsimikas S Prog Cardiovasc Dis; 2016; 59(2):135-144. PubMed ID: 27497506 [TBL] [Abstract][Full Text] [Related]
33. Autotaxin interacts with lipoprotein(a) and oxidized phospholipids in predicting the risk of calcific aortic valve stenosis in patients with coronary artery disease. Nsaibia MJ; Mahmut A; Boulanger MC; Arsenault BJ; Bouchareb R; Simard S; Witztum JL; Clavel MA; Pibarot P; Bossé Y; Tsimikas S; Mathieu P J Intern Med; 2016 Nov; 280(5):509-517. PubMed ID: 27237700 [TBL] [Abstract][Full Text] [Related]
36. [The diagnostic significance of lipoprotein(a)]. Mayer J; Brauer P; Solleder EM Dtsch Med Wochenschr; 1992 Nov; 117(48):1845-8. PubMed ID: 1451650 [No Abstract] [Full Text] [Related]
37. Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases. Kronenberg F Cardiovasc Drugs Ther; 2016 Feb; 30(1):87-100. PubMed ID: 26896185 [TBL] [Abstract][Full Text] [Related]
38. Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis. Capoulade R; Chan KL; Yeang C; Mathieu P; Bossé Y; Dumesnil JG; Tam JW; Teo KK; Mahmut A; Yang X; Witztum JL; Arsenault BJ; Després JP; Pibarot P; Tsimikas S J Am Coll Cardiol; 2015 Sep; 66(11):1236-1246. PubMed ID: 26361154 [TBL] [Abstract][Full Text] [Related]